Managing multiple sclerosis in the Covid19 era: a review of the literature and consensus report from a panel of experts in Saudi Arabia

Disease-modifying therapies (DMT) for relapsing-remitting MS (RRMS) act on the immune system, suggesting a need for caution during the SARS-CoV2/Covid-19 pandemic. A group of experts in MS care from Saudi Arabia convened to consider the impact of Covid-19 on MS care in that country, and to develop c...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Jumah, Mohammed, Abulaban, Ahmad, Aggad, Hani, Al Bunyan, Reem, AlKhawajah, Mona, Al Malik, Yaser, Almejally, Mousa, Alnajashi, Hind, Alshamrani, Foziah, Bohlega, Saeed, Cupler, Edward J, ElBoghdady, Ahmed, Makkawi, Seraj, Qureshi, Shireen, Shami, Sahar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992311/
https://www.ncbi.nlm.nih.gov/pubmed/33857897
http://dx.doi.org/10.1016/j.msard.2021.102925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992311/
https://www.ncbi.nlm.nih.gov/pubmed/33857897
http://dx.doi.org/10.1016/j.msard.2021.102925

Ejemplares similares